Campbell B K, Stark M J
CODA, Program in Substance Abuse, Portland, Oregon.
Int J Addict. 1990 Dec;25(12):1467-74. doi: 10.3109/10826089009056231.
Sixteen opiate, 16 amphetamine, 34 cocaine, and 29 marijuana abusers were administered the Million Clinical Multiaxial Inventory and the SCL-90R symptom checklist at treatment admission. Results showed that the combined drug group had levels of psychopathology that were significantly higher than those of a normative psychiatric sample. The four drug groups differed significantly from one another on four scales of the SCL-90R, with the amphetamine group differing from the others on two of the scales. These findings reveal high levels of psychopathology and considerable heterogeneity of symptoms within and across groups of substance abusers at treatment admission.
在治疗入院时,对16名阿片类药物滥用者、16名苯丙胺滥用者、34名可卡因滥用者和29名大麻滥用者进行了百万临床多轴问卷和症状自评量表90修订版(SCL-90R)测试。结果显示,混合药物组的精神病理学水平显著高于正常精神科样本。这四个药物组在SCL-90R的四个量表上彼此有显著差异,其中苯丙胺组在两个量表上与其他组不同。这些发现揭示了药物滥用者在治疗入院时,其精神病理学水平较高,且组内和组间症状存在相当大的异质性。